6283-27-8 Usage
Uses
Used in Food and Beverage Industry:
Diammonium malate is used as a food additive to provide nitrogen for yeast during the fermentation process, particularly in the wine industry, and to help regulate acidity. It enhances the fermentation process and contributes to the overall quality of the final product.
Used in Pharmaceutical Production:
Diammonium malate is used as a component in the production of certain pharmaceuticals. Its properties make it suitable for use in the synthesis of various medications, contributing to the development of new and effective treatments.
Used in Chemical Synthesis:
Diammonium malate is employed as a component in the synthesis of other chemicals. Its unique chemical structure allows it to be a valuable building block in the creation of a range of chemical products, expanding its applications beyond the food and pharmaceutical industries.
Check Digit Verification of cas no
The CAS Registry Mumber 6283-27-8 includes 7 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 4 digits, 6,2,8 and 3 respectively; the second part has 2 digits, 2 and 7 respectively.
Calculate Digit Verification of CAS Registry Number 6283-27:
(6*6)+(5*2)+(4*8)+(3*3)+(2*2)+(1*7)=98
98 % 10 = 8
So 6283-27-8 is a valid CAS Registry Number.
InChI:InChI=1/C4H6O5.H3N/c5-2(4(8)9)1-3(6)7;/h2,5H,1H2,(H,6,7)(H,8,9);1H3
6283-27-8Relevant academic research and scientific papers
NOVEL PROCESS
-
Page/Page column 24-25, (2011/09/30)
The present invention relates to an improved process for preparing acid addition salts of sunitinib, in particular sunitinib (2S)-2-hydroxybutanedioate (I). The invention also relates to compositions comprising sunitinib acid addition salts such as sunitinib (2S)-2- hydroxybutanedioate (I) and to the use of said compositions in the treatment of disease.
NOVEL PROCESS
-
Page/Page column 34, (2011/11/01)
The present invention relates to novel processes for the preparation of sunitinib and salts thereof, in particular sunitinib (2S)-2-hydroxybutanedioate. The invention further relates to novel intermediates, their use in the preparation of sunitinib or salts thereof and to processes for the preparation of said intermediates. The invention also relates to compositions comprising sunitinib or its pharmaceutically acceptable salts.
